RESUMO
Background: bromide is found naturally in groundwater and surface water. The rapid growth of industrial activities, drainage of surface runoff, and use of methyl bromide in pesticides has increased bromide discharge to the environment. Disinfection of water-containing bromide causes the creation of additional products of organo-halogenated that are considered cancer-causing agents. In this study, the effect and optimization of factors in removal of this ion was evaluated by using the nano-photocatalytic UV/ZnO process
Methods: this analytical study was conducted in a batch system by the phenol-red method. The test design was performed through the analysis model of multi-factor variance with 99 subjects, while the main, interactive, and reciprocal effects of variables, such as reaction time, catalyst concentration, bromide concentration, and pH at different levels of each factor, were analysed by using SPSS version 16
Results: the main, interactive, and reciprocal effects of factors were significant in three different levels with P < 0.001, and the optimal level of the factors reaction time, catalyst concentration, bromide concentration, and pH were 120 minutes, 0.5, 0.1, and 7 mg/L, respectively, by using the Schaffer test. The highest removal efficiency of 95% was obtained at least 91.56 and a maximum of 94.76% was obtained under optimal conditions of all factors
Conclusion: the results show that by optimization of factors, this process can be effectively used to remove bromide from aquatic environments
RESUMO
Objective To compare the safety and efficacy of combined therapy using sildenafil and tamsulosin for management of acute urinary retention (AUR) with tamsulosin alone in patients with benign prostate hyperplasia (BPH). Materials and Methods 101 patients were enrolled in a randomized placebo-controlled study from June 2009 to April 2012. Patients presenting with an initial episode of spontaneous AUR underwent urethral catheterization and then prospectively randomized to receive tamsulosin 0.4mg plus sildenafil 50mg in group A and tamsulosin 0.4mg plus placebo in group B for three days. Urethral catheter was removed three days after medical treatment and patient’s ability to void assessed at the day after catheter removal and seven days later. Patients who voided successfully were followed at least for three months. Results Mean age of patients was 59.64 ± 3.84 years in group A and 60.56 ± 4.12 years in group B (p value = 0.92). Mean prostate volume and mean residual urine were comparable between both groups (p value = 0.74 and 0.42, respectively). Fifteen patients in group A (success rate: 70%) and nineteen patients in group B (success rate: 62.7%) had failed trial without catheter (TWOC) at 7th day following AUR (p value = 0.3). No significant difference was noted between both groups regarding the rate of repeated AUR at one month and three month follow-up period (p = 0.07 and p = 0.45, respectively). Conclusion It seems that combination therapy by using 5-phosphodiesterase inhibitor and tamsulosin has no significant advantages to improve urinary retention versus tamsulosin alone. .